HEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST JACT+

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05,06 report with the FDA on 2015-07-15 for HEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST JACT+ manufactured by International Technidyne Corp..

Event Text Entries

[17852815] Healthcare professional reported out of range high readings with hemochron signaure elite and act plus system. A (b)(6) male patient was receiving iv heparin while on cardivascular bypass during an aortic valve repair procedure. The target act was 440-480 seconds. The hemochron signature elite and act plus system reported two consecutive act results that were out of range high (>1005 seconds). Times of adminisration and dosage of heparin were not specified. The case continued and a subsequent act measured with the sme hemochron signaure elite and act plus system was 379 seconds, which was below the target act range. Both electronic and liquid quality controls passed. The procedure was as focompleted sucessfully and no patient injury or adverse events were reported.
Patient Sequence No: 1, Text Type: D, B5


[18141247] (b)(4). The serial number of the hemochron signature elite instrument used during this procedure is (b)(4). Assessment of (b)(4) concluded that it was unrelated to the complaint. No other ncrs or other anomalies related to the complaint were identified. No current lot or product trends. No capa. Despite multiple requests by itc for the heparin doses and timing of drug administration, the end user has refused to provide the requested information. Itc will continue following this complaint and will report a follow-up mdr if this information becomes available. Itc has requested all data required for form 3500a.
Patient Sequence No: 1, Text Type: N, H10


[37074575] Follow-up #1.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2248721-2015-00050
MDR Report Key4921005
Report Source05,06
Date Received2015-07-15
Date of Report2015-06-17
Date of Event2015-06-10
Date Mfgr Received2015-06-17
Device Manufacturer Date2015-03-01
Date Added to Maude2015-07-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street8 OLSEN AVE.
Manufacturer CityEDISON NJ 08820
Manufacturer CountryUS
Manufacturer Postal08820
Manufacturer Phone8582632490
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON JR. MICROCOAGULATION ACT PLUS TEST
Product CodeJBP
Date Received2015-07-15
Model NumberJACT+
Catalog NumberJACT+
Lot NumberC5JAC817
Device Expiration Date2016-06-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerINTERNATIONAL TECHNIDYNE CORP.
Manufacturer AddressEDISON NJ 08820 US 08820


Patients

Patient NumberTreatmentOutcomeDate
10 2015-07-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.